PALO ALTO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Wealthfront, a tech-driven financial platform helping digital natives turn their savings into wealth, today announced that it has launched the ...
The U.S.-based tax and legal services firm plans to fold in some international units from the larger Andersen Global network. Formed from the combination of Germany’s Krauss-Maffei Wegmann and ...
DALLAS, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. (Nasdaq: ASST) (“Strive” or the “Company”) today announced the upsizing and pricing of its initial public offering (the “offering”) on November 5 ...
AUSTIN, Texas, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Ethos, a leading life insurance technology company on a mission to democratize access to life insurance, today announced the pricing of its initial ...
Hosted on MSN
Medline IPO: Should you buy MDLN stock?
The market for initial public offerings (IPOs) was gaining momentum heading into the fourth quarter (Q4) of 2025, but quickly lost steam as the record-long government shutdown put a short-term halt to ...
ALISO VIEJO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (SGP) (“SpyGlass Pharma”), a late-stage biopharmaceutical company, today announced the pricing of its initial public ...
MOZAYYX Acquisition Corp. (NYSE: MZYX.U) (the 'Company”) today announced that it closed its upsized initial public offering of 30,000,000 units at $10.00 per unit, including the issuance of 3,900,000 ...
BitGo Holdings, Inc. (“BitGo”), the digital asset infrastructure company, today announced the launch of its initial public offering of 11,821,595 shares of Class A common stock pursuant to a ...
QumulusAI, a Marietta, Ga.-based cloud infrastructure company, filed for an initial public offering. The company is looking to list its shares on Nasdaq under the symbol "QMLS," according to a ...
SÃO PAULO--(BUSINESS WIRE)--PicPay announced today the pricing of its initial public offering, consisting of an offering of 22,857,143 Class A common shares pursuant to a registration statement on ...
ANTWERP, Belgium, February 5, 2026 (GLOBE NEWSWIRE) – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results